Lyell Immunopharma, Inc.

LYEL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$123,575$98,804$120,328$105,597
Short-Term Investments$196,049$177,986$180,849$264,930
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$8,577$5,424$8,001$9,067
Total Curr. Assets$328,201$282,214$309,178$379,594
Property Plant & Equip (Net)$56,634$60,066$67,765$72,939
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$19,000$39,059$47,949$32,014
Tax Assets$0$0$0$0
Other NC Assets$4,130$4,114$4,906$6,312
Total NC Assets$79,764$103,239$120,620$111,265
Other Assets$0$0$0$0
Total Assets$407,965$385,453$429,798$490,859
Liabilities
Payables$2,568$3,379$3,728$5,366
Short-Term Debt$0$8,510$8,238$7,974
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$29,310$25,014$29,319$40,448
Total Curr. Liab.$31,878$36,903$41,285$53,788
LT Debt$44,285$46,597$48,851$50,994
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,681$3,030$3,141$3,253
Total NC Liab.$46,966$49,627$51,992$54,247
Other Liabilities$0$0$0$0
Cap. Leases$0$55,107$57,089$58,968
Total Liabilities$78,844$86,530$93,277$108,035
Equity
Pref Stock$0$0$0$0
Common Stock$2$1$30$29
Retained Earnings-$1,478,831-$1,439,985-$1,397,301-$1,345,106
AOCI$201$57$158$291
Other Equity$1,807,749$1,738,850$1,733,634$1,727,610
Total Equity$329,121$298,923$336,521$382,824
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$407,965$385,453$429,798$490,859
Net Debt-$79,290-$43,697-$63,239-$46,629
Lyell Immunopharma, Inc. (LYEL) Financial Statements & Key Stats | AlphaPilot